{
    "2021-12-10": [
        [
            {
                "time": "",
                "original_text": "万泰生物：公司二价HPV疫苗3000万支/年的总产能已综合考虑定期设备检修等因素",
                "features": {
                    "keywords": [
                        "万泰生物",
                        "二价HPV疫苗",
                        "3000万支/年",
                        "总产能",
                        "设备检修"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "生物医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "2021-12-09",
                "original_text": "万泰生物12月9日现2笔大宗交易",
                "features": {
                    "keywords": [
                        "万泰生物",
                        "大宗交易",
                        "12月9日",
                        "2笔"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "生物医药"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            }
        ]
    ]
}